調剤薬局の市場規模、シェア、成長分析：治療領域別、年齢層別、タイプ別、無菌性別、地域別 - 産業予測 2025～2032年

調剤薬局の市場規模は2023年に152億米ドルとなり、予測期間（2025-2032年）のCAGRは5.8%で、2024年の160億8,000万米ドルから2032年には252億5,000万米ドルに成長する見通しです。

調剤薬局市場は、特許切れの増加、平均寿命の延長、高齢者層の増加など、いくつかの重要な要因によって成長が見込まれています。調剤薬局は、患者の特定のニーズに応える個別化された医薬品の作成を専門としており、市販の選択肢が利用できない場合も多いです。これらの医薬品は、免許を持つ医師の処方に従って、風味のある液体、クリーム、ゲル、坐薬など多様な剤形に調合することができます。2021年には、成人が市場シェアの47%を占め、調剤薬局は日々の健康をサポートする栄養補助食品も提供しています。さらに、不適切なライフスタイルの選択に関連した慢性疾患の有病率の増加は、配合ソリューションの需要をさらに煽り、今後数年間の市場拡大を加速させると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 顧客と購買基準の分析

調剤薬局市場規模：治療領域別& CAGR（2025-2032）

• 市場概要
• ホルモン補充療法
• 疼痛管理
• 専門医薬品
• 皮膚科
• 栄養補助食品
• その他

調剤薬局市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 小児
• 成人
• 高齢者

調剤薬局市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 医薬品成分変更（PIA）
• 現在利用できない医薬品製造（CUPM）
• 医薬品投与量変更（PDA）
• その他

調剤薬局市場規模：無菌性別& CAGR（2025-2032）

• 市場概要
• 滅菌済み
• 非滅菌

調剤薬局市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• B. Braun Melsungen AG（Germany）
• Fagron NV（Belgium）
• Fresenius Kabi AG（Germany）
• Becton, Dickinson and Company（United States）
• McGuff Compounding Pharmacy Services Inc.（United States）
• Village Compounding Pharmacy（United States）
• Dougherty's Pharmacy, Inc.（United States）
• Institutional Pharmacy Solutions（United States）
• Lorraine's Pharmacy（United States）
• Triangle Compounding Pharmacy（United States）
• Custom Med Apothecary（United States）
• Olympia Pharmacy（United States）
• Precision Compounding Pharmacy（United States）
• College Pharmacy（United States）

結論と推奨事項

Compounding Pharmacy Market size was valued at USD 15.2 billion in 2023 and is poised to grow from USD 16.08 billion in 2024 to USD 25.25 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The Compounding Pharmacy Market is poised for growth driven by several key factors, including a rise in patent expirations, longer life expectancy, and a growing elderly demographic. Compounding pharmacies specialize in creating personalized medications that cater to the specific needs of patients, often when commercial options are unavailable. These medications can be formulated into diverse dosage forms such as flavored liquids, creams, gels, and suppositories, as prescribed by licensed physicians. In 2021, adults constituted 47% of the market share, with compounding pharmacies also offering nutritional supplements to support daily wellness. Furthermore, the increasing prevalence of chronic diseases linked to poor lifestyle choices will further fuel the demand for compounded solutions, accelerating market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Compounding Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Compounding Pharmacy Market Segments Analysis

Global Compounding Pharmacy Market is segmented by Therapeutic Area, Age Cohort, Type, Sterility and region. Based on Therapeutic Area, the market is segmented into Hormone Replacement Therapy, Pain Management, Specialty Drugs, Dermatology, Nutritional Supplements and Others. Based on Age Cohort, the market is segmented into Pediatric, Adult and Geriatric. Based on Type, the market is segmented into Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Others. Based on Sterility, the market is segmented into Sterile and Non-sterile. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Compounding Pharmacy Market

The Compounding Pharmacy market is expected to experience a compound annual growth rate (CAGR) exceeding 6% until 2028, largely fueled by the growing preference for oral pharmaceuticals, such as tablets and capsules. This rise in demand is attributed to the fact that many medical conditions can be most effectively managed through oral administration of medications. As patients increasingly seek convenient and effective treatment options, the reliance on orally delivered pharmaceuticals is set to expand, further propelling growth in the Compounding Pharmacy sector. This trend signifies a notable shift towards customized solutions in the pharmaceutical industry.

Restraints in the Compounding Pharmacy Market

The Compounding Pharmacy market is facing challenges due to an increase in the number of drugs that are prohibited from being compounded in large quantities. For instance, the U.S. FDA announced in June 2015 that it would restrict certain medications, including acetaminophen, aprotinin (Trasylol), ondansetron hydrochloride (Zofran), and bromocriptine mesylate (Tylenol), from being compounded by external institutions. This regulation could lead to a significant decline in demand for commonly compounded pharmaceuticals such as Tylenol, thereby adversely impacting the sales potential of compounded products from complex drug pharmacies. This restraint poses a notable hurdle for market growth and sustainability.

Market Trends of the Compounding Pharmacy Market

The compounding pharmacy market is poised for significant growth, driven by heightened research and development in topical formulations such as gels, creams, and ointments. As pharmaceutical companies prioritize innovative solutions to meet specific patient needs and preferences, the demand for customized medications continues to rise. Factors such as an increasing prevalence of skin-related issues, the rising geriatric population, and a growing emphasis on personalized medicine are further propelling this trend. Consequently, the compounding pharmacy sector is becoming a vital component of the healthcare landscape, paving the way for advanced therapeutic options tailored to individual patient requirements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Compounding Pharmacy Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Hormone Replacement Therapy
• Pain Management
• Specialty Drugs
• Dermatology
• Nutritional Supplements
• Others

Global Compounding Pharmacy Market Size by Age Cohort & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Compounding Pharmacy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

Global Compounding Pharmacy Market Size by Sterility & CAGR (2025-2032)

• Market Overview
• Sterile
• Non-sterile

Global Compounding Pharmacy Market Size & CAGR (2025-2032)

• North America (Therapeutic Area, Age Cohort, Type, Sterility)
  • US
  • Canada
• Europe (Therapeutic Area, Age Cohort, Type, Sterility)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Area, Age Cohort, Type, Sterility)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Area, Age Cohort, Type, Sterility)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Area, Age Cohort, Type, Sterility)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fagron NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McGuff Compounding Pharmacy Services Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Village Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dougherty's Pharmacy, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Institutional Pharmacy Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lorraine's Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triangle Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Custom Med Apothecary (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympia Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• College Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations